Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Georgia Fogden-King's Articles

Silence Therapeutics Appoints David Horn Solomon as Chief Executive Officer

Silence Therapeutics plc, a leader in the discovery and development of novel RNA therapeutics announces today the appointment of Dr David Horn Solomon as its new Chief Executive Officer (CEO) effective immediately.  David will head the Leadership Team and joins the Board of Directors. 

AMSBIO Launch New Screening Company

ScreenIn3D (Glasgow, UK) is a new joint venture company set up by AMSBIO and the University of Strathclyde exploiting the latest advances in microfluidics and 3D culture to develop a novel microfluidic screening platform.

Adaptix Imaging is winner of The Oxford Science Park Innovation Award 2018

New 3D approach to X-ray imaging recognised as part of Oxfordshire Business Awards

3D-iPSC Matrix Enables More Accurate In Vivo Predictions

AMSBIO announces MyEZGel™ 3D-iPSC Matrix - a powerful new tool for in vitro 3D human induced pluripotent stem cell (hiPSC) culture, enabling more accurate in vivo predictions in life science research and development.

£2.5bn British Patient Capital Programme launched to enable long-term investment in innovative companies across the UK

The British Business Bank is launching British Patient Capital, a new £2.5bn programme designed to enable long-term investment in high growth potential companies across the UK led by ambitious entrepreneurs who want to build successful, world-class businesses.

Cell Culture Medium for Clinical Research

AMSBIO announces the launch of StemFit® Basic03 clinical grade stem cell culture for regenerative medicine

Get up to £200K to accelerate your life sciences startup

Twice a year we invest up to* £200,000 in startups solving global challenges with life itself.

Aurelia Bioscience 

Aurelia Bioscience is a contract research organisation (CRO) specialising in bioassay development and compound screening.

Ground-breaking medical blood treatment passes £1.75 million in funding

MediSieve Ltd, the team behind an innovative blood filtration device, are happy to announce the company has received over £1.75 million in funding.

Orbit Discovery raises £6.9m for peptide library

Oxford Sciences Innovation leads round into Orbit Discovery, an Oxford University spinout developing a peptide platform.

Pages: Previous1234567...14NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.